Brupharma
ActiveBrupharma has been active since 1970 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €174k and a net result of €-743. Equity is shrinking by ~3.9% per year across the filed fiscal years. Its solvency ranks better than 62% of 18237 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).
Checked score
Score 2025
80
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability68▼-2
Solvency73▼-9
Growth32=
Track record100
Bankruptcy probability, 12 months
0.5%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €13k at 30 days acceptable
Liquidity ample (current ratio 3.23 against 4.12 in 2024; short-term debt: 16.6% and cash: 51% of total assets), but 51.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-07-2026, 25 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
25 d early
2024
28 d early
2023
30 d late
2022
30 d late
2021
17 d early
2020
25 d early
2019
24 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€174k▼ 22.5%
2024 · €225k
2018: €272k
2019: €282k
2020: €275k
2021: €256k
2022: €256k
2023: €258k
2024: €225k
2018 → 2025
Total assets
€360k▼ 8.9%
2024 · €395k
2018: €833k
2019: €762k
2020: €497k
2021: €483k
2022: €411k
2023: €394k
2024: €395k
2018 → 2025
Net result
€-743
2024 · €4k
2018: €9k
2019: €10k
2020: €-6k
2021: €-20k
2022: €136
2023: €2k
2024: €4k
2018 → 2025
Working capital
€133k▼ 0.6%
2024 · €134k
2018: €139k
2019: €183k
2020: €-1k
2021: €59k
2022: €6k
2023: €75k
2024: €134k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€256k-€256k▲ 0.1%€258k▲ 0.7%€225k▼ 12.5%€174k▼ 22.5%
Operating result€-12k-€7k€12k▲ 64.0%€14k▲ 17.7%€8k▼ 44.5%
Net result€-20k-€136€2k▲ 1,255%€4k▲ 102%€-743
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 44% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €360k
Fixed assets
€167k▼ 23.4%
Current assets
€193k▲ 9.1%
Equity and liabilities €360k
Equity
€174k▼ 22.5%
Debt
€186k▲ 9.2%
The debt ratio rises from 43.0% to 51.5%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€67k▼
2024 · €106k
Cash flow
€59k▼
2024 · €95k
Solvency
48.5%▼
2024 · 57.0%
Current ratio
3.23▼
2024 · 4.12
Quick ratio
3.23▼
2024 · 4.12
Debt / equity
1.06▲
2024 · 0.75
ROE
-0.4%▼
2024 · 1.6%
ROA
-0.2%▼
2024 · 0.9%
Interest coverage
8.04▼
2024 · 11.18
Debt
€186k▲
2024 · €170k
Debt ≤ 1 year
€60k▲
2024 · €43k
Debt > 1 year
€117k=
2024 · €117k
Income taxes
€1k▼
2024 · €2k
Staff costs
€4k▲
2024 · €4k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€395k€360k▼
Fixed assets21/28€218k€167k▼
Tangible fixed assets22/27€218k€167k▼
Land and buildings22€130k€121k▼
Plant, machinery and equipment23€34k€20k▼
Furniture and vehicles24€54k€26k▼
Financial fixed assets28€42€42=
Current assets29/58€177k€193k▲
Amounts receivable within one year40/41€2k€5k▲
Trade receivables40-€4
Other amounts receivable41€2k€5k▲
Current investments50/53€150k-
Cash at bank and in hand54/58€20k€184k▲
Deferred charges and accrued income490/1€5k€5k▼
Equity and liabilities
Total equity and liabilities10/49€395k€360k▼
Equity10/15€225k€174k▼
Contributions10/11€19k€19k=
Reserves13€207k€156k▼
Tax-exempt reserves132€1k€1k=
Distributable reserves133€206k€155k▼
Amounts payable17/49€170k€186k▲
Amounts payable after more than one year17€117k€117k=
Other amounts payable178/9€117k€117k=
Amounts payable within one year42/48€43k€60k▲
Trade debts44€5k€4k▼
Suppliers440/4€5k€4k▼
Advances received on contracts in progress46€9€9=
Taxes, remuneration and social security45€2k€3k▲
Taxes450/3€2k€3k▲
Remuneration and social security454/9€272€280▲
Other amounts payable47/48€36k€53k▲
Accrued charges and deferred income492/3€9k€8k▼
Income statement
Code20242025
Remuneration, social security and pensions62€4k€4k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€92k€59k▼
Other operating charges640/8€5k€4k▼
Gross operating margin9900€115k€76k▼
Operating profit (loss)9901€14k€8k▼
Financial income75/76B€780€895▲
Recurring financial income75€780€895▲
Financial charges65/66B€9k€8k▼
Recurring financial charges65€9k€8k▼
Profit (loss) for the period before taxes9903€6k€460▼
Income taxes67/77€2k€1k▼
Profit (loss) for the period9904€4k€-743▼
Profit (loss) for the period to be appropriated9905€4k€-743▼
Appropriation of the result
Profit (loss) to be appropriated9906€4k€-743▼
Transfer from equity791/2€36k€51k▲
Transfer to equity691/2€4k-
To other reserves6921€4k-
Profit to be distributed694/7€36k€50k▲
Return on contributions (dividend)694€36k€50k▲
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
06-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
03-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
31-12
Financial
Liquidity times 5current ratio 7.92
Current ratio from 1.76 to 7.92.
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 30 days late
2022
31-12
Financial
Back to profitnet €136
Net result €136 after 2 loss-making years.
14-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Weakest financial yearnet €-20k
Net result drops to €-20k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity quadruplescurrent ratio 3.64
Current ratio from 0.93 to 3.64.
06-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
07-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial
Highest result since 2018net €10k ▲7.8%
Net result €10k, the highest in the series.
16-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
17-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
20-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brugge · 1 establishment unit since 1970
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Smedenstraat 738000 BruggeGround area
82 m²
Building footprint
81 m²
Volume, LiDAR
898 m³
Parcel 31804D1566/00B000, Flanders · tallest building 12.8 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
Smedenstraat 73, 8000 Brugge
since 19702.229.724.251
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 31804D1566/00B000 | Flanders | 82 m² | 1 · 81 m² | 12.8 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2024 · 1 entry · 2,000 EUR awarded · 2,000 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2024 | 1 | 2,000 EUR | 2,000 EUR |
Schemes
Hinderpremie bij openbare werken
Similar companies · same sector, comparable size
APOTHEEK LATEM
BE 0644.587.863
Sint-Martens-Latem · Eq €174k
PHARMACIE THIRY ANNE
BE 0643.904.212
Court-Saint-Etienne · Eq €175k
Pharmacie KIEFFER
BE 0882.520.945
Arlon · Eq €175k
Pharmacie Delvigne
BE 0408.150.561
Jemeppe-sur-Sambre · Eq €175k
Pharmacie de MAZY
BE 0418.958.242
Gembloux · Eq €174k
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,576 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded12-11-1970
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 49 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryPhone:050/33.80.67